Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study*-Reference-Cited by-同舟云学术

Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study*

Author:

Campbell Garland A¹,Patrie James T²,Gaylinn Bruce D³,Thorner Michael O³,Bolton Warren K¹

Affiliation:

1. Division of Nephrology, University of Virginia Health Sciences Center, Charlottesville, VA, USA

2. PBHS Public Health Sciences Administration, Public Health Sciences, University of Virginia Health Sciences Center, Charlottesville, VA, USA

3. Division of Endocrinology, University of Virginia Health Sciences Center, Charlottesville, VA, USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

Reference47 articles.

2. Malnutrition and wasting in renal disease;Muscaritoli;Curr Opin Clin Nutr Metab Care,2009

5. Predictors of mortality in hemodialysis patients [abstract];Goldwasser;J Am Soc Nephrol,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Uremic Toxicity;Handbook of Dialysis Therapy;2023